Myhep Lvir tablet is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, and is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
The most common side-effects observed with treatment with Sofosbuvir and Ledipasvir for 8, 12, or 24 weeks are fatigue and headache.
Use with other drugs containing sofosbuvir, including SOVALDI, is not recommended.
What is the use of Sofosbuvir and Ledipasvir?
The combination medicine Sofosbuvir and Ledipasvir is recommended to treat chronic hepatitis C (CHC) genotype 1 infection.
When was Ledipasvir and Sofosbuvir approved by the FDA?
The FDA approved the combination medicine Sofosbuvir and Ledipasvir in 2014.
What drug class is Sofosbuvir and Ledipasvir?
Sofosbuvir and Ledipasvir combination comes under the class of nucleotide polymerase inhibitors.
The Indian Generic Medicines is a Consultancy and Service company providing access to genuine generic medicines to patients all across the world. We also have own pharmacy named as Indian Generic Medicines which work under compliant distribution guidelines.
© 2024 Indian Generic Medicines. All rights reserved.
